Immunogenicity and Safety Study in Infants of GlaxoSmithKline Biologicals' Infanrix Hexa™ (DTPa-HBV-IPV/Hib) Vaccine
Conditions: Diphtheria; Hepatitis B; Haemophilus Influenzae Type b Disease; Poliomyelitis; Pertussis; TetanusIntervention: Biological: Infanrix hexa™Sponsors: GlaxoSmithKline; GlaxoSmithKlineActive, not recruiting - verified January 2013 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 12, 2011 Category: Research Source Type: clinical trials